Skip to content

Psychotic disorder: positive, negative and cognitive symptoms in daily life

Psychotic disorder: positive, negative and cognitive symptoms in daily life - CogHyg

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41303
Enrollment
200
Registered
2011-06-20
Start date
2011-08-18
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychosis schizophrenia

Interventions

None listed

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
12 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for the early psychosis group are: (i) the presence of attenuated psychotic symptoms, brief limited intermittent psychotic symptoms, genetic risk or the occurrence of a psychotic episode according to DSM-IV criteria, , (ii) age 15-35 years, (iii) sufficient knowledge of the Dutch language.;Inclusion criteria for the chronic psychosis group are: (i) life time occurrence of a psychotic episode according to DSM-IV criteria, (ii) illness onset > 6 years, (iii) age 25-55 years, (iv) sufficient knowledge of the Dutch language.

Exclusion criteria

Exclusion criteria: Exclusion criteria for the early psychosis group are: (i) onset of symptoms >2 years, (ii) frequent drug use (>2 times a week), (iii) Mental Retardation (IQ score 2 times a week), (iii) Mental Retardation (IQ score

Design outcomes

Primary

MeasureTime frame
Cognition assessed in daily life Social cognition assessed in daily life Negative symptoms assessed in daily life Positive symptoms assessed in daily life Fluctuations in both cognition and social cognition in daily life and the influence of these fluctuations on positive and negative symptoms

Secondary

MeasureTime frame
Saliva samples will be collected for the purpose of molecular genetic studies. These studies aim at selecting SNPs (parts of the DNA where one nucleotide is different from one person to another) that contribute to the psychosis phenotype.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)